Further to above post, one would suggest that if Keytruda and
Lenvima combo are going to be available at very low cost to
Australian public, then Imugene as an Australian company could
expect to be on Public Pharmaceutical list to treat all cancers,
as a combo treatment. Makes good sense to me anyway
Media Thread, page-9340
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $157.7K | 3.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 3378517 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3189511 | 30 |
View Market Depth
| Last trade - 13.39pm 01/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |